BrightSpring Health Services Inc. (BTSG) — RQD Stock Rating Cockpit
BrightSpring Health Services Inc. (BTSG) carries a Roarable Rating of C (Hold) with 65/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Decent core business (12% profit margin), though cash flow growth is moderate rather than explosive right now.
Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.
Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.
JEV AI Jury Split (Battleground) on BTSG
5.5% ROIC with 11.8% gross margin and 3.31% FCF yield.
Altman-Z 3.92 and Piotroski 7/9 pass balance-sheet audit.
Put/Call 0.84x with 22/40 institutional & insider flow.
- ✓Established market leader in Health Care with deep daily trading liquidity.
- !Priced at 63x earnings—high expectations leave less room for a lukewarm quarter.
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live BTSG Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
BTSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +28.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BTSG today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BTSG. Explore sector supply chains on /butterfly.
BTSG Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDShould I buy, hold, or sell BTSG stock right now?
BrightSpring Health Services Inc. (BTSG) currently earns a Roarable Rating of C (Hold — HOLD) with 65/100 RQD Confidence. Solid 12% profit margin (6% return on capital), mixed timing at 63x P/E—hold if owned, no rush to chase.
What is BTSG's 12-month price target and RQD AI Jury consensus?
BTSG's 12-month base price target is $62.12 (range $48.45 to $77.44), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.